Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Mast cell activation after adenosine inhalation challenge in patients with bronchial asthma.

Bochenek G, Nizankowska E, Gielicz A, Szczeklik A.

Allergy. 2008 Jan;63(1):140-1. No abstract available.

PMID:
18053025
2.

FCERIA gene promoter polymorphisms: lack of association with aspirin hypersensitivity in whites.

Sanak M, Potaczek DP, Mastalerz L, Nizankowska E, Szczeklik A.

J Allergy Clin Immunol. 2007 May;119(5):1280-1. Epub 2007 Mar 1. No abstract available.

PMID:
17335883
3.

Novel exon 2A of the high-affinity receptor for the IgE alpha-chain gene (FCER1A) and autoimmunity in patients with asthma or urticaria.

Potaczek DP, Sanak M, Nizankowska E, Mastalerz L, Dziedzina S, Grzywacz M, Szczeklik A.

Ann Allergy Asthma Immunol. 2006 Nov;97(5):711-2. No abstract available.

PMID:
17165285
4.

The alpha-chain of high-affinity receptor for IgE (FcepsilonRIalpha) gene polymorphisms and serum IgE levels.

Potaczek DP, Sanak M, Mastalerz L, Setkowicz M, Kaczor M, Nizankowska E, Szczeklik A.

Allergy. 2006 Oct;61(10):1230-3.

PMID:
16942574
5.

[Functional assessment of posterior cordotomy in patients with bilateral vocal fold paralysis].

Strek P, Zagólski O, Swierczyńska M, Nizankowska E, Szałapata-Kraśniak M.

Otolaryngol Pol. 2004;58(3):451-7. Polish.

PMID:
15311586
6.

Plasma 9alpha,11beta-PGF2, a PGD2 metabolite, as a sensitive marker of mast cell activation by allergen in bronchial asthma.

Bochenek G, Nizankowska E, Gielicz A, Swierczyńska M, Szczeklik A.

Thorax. 2004 Jun;59(6):459-64.

7.

Diagnosis, prevention and treatment of aspirin-induced asthma and rhinitis.

Bochenek G, Bánska K, Szabó Z, Nizankowska E, Szczeklik A.

Curr Drug Targets Inflamm Allergy. 2002 Mar;1(1):1-11. Review.

PMID:
14561202
8.

Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib.

Gyllfors P, Bochenek G, Overholt J, Drupka D, Kumlin M, Sheller J, Nizankowska E, Isakson PC, Mejza F, Lefkowith JB, Dahlén SE, Szczeklik A, Murray JJ, Dahlén B.

J Allergy Clin Immunol. 2003 May;111(5):1116-21.

PMID:
12743579
9.
10.

Clinical and genetic features underlying the response of patients with bronchial asthma to treatment with a leukotriene receptor antagonist.

Mastalerz L, Nizankowska E, Sanak M, Mejza F, Pierzchalska M, Bazan-Socha S, Bestynska-Krypel A, Cmiel A, Szczeklik A.

Eur J Clin Invest. 2002 Dec;32(12):949-55.

PMID:
12534456
11.

Protection against exercise-induced bronchoconstriction by montelukast in aspirin-sensitive and aspirin-tolerant patients with asthma.

Mastalerz L, Gawlewicz-Mroczka A, Nizankowska E, Cmiel A, Szczeklik A.

Clin Exp Allergy. 2002 Sep;32(9):1360-5.

PMID:
12220476
12.
13.

Aspirin-induced rhinitis and asthma.

Szczeklik A, Nizankowska E, Sanak M, Swierczynska M.

Curr Opin Allergy Clin Immunol. 2001 Feb;1(1):27-33. Review.

PMID:
11964666
14.

Analgesics and asthma.

Szczeklik A, Nizankowska E, Mastalerz L, Szabo Z.

Am J Ther. 2002 May-Jun;9(3):233-43. Review.

PMID:
11941383
15.

Myocardial ischemia possibly mediated by cysteinyl leukotrienes.

Szczeklik A, Nizankowska E, Mastalerz L, Bochenek G.

J Allergy Clin Immunol. 2002 Mar;109(3):572-3. No abstract available.

PMID:
11898009
16.

Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.

Dahlén SE, Malmström K, Nizankowska E, Dahlén B, Kuna P, Kowalski M, Lumry WR, Picado C, Stevenson DD, Bousquet J, Pauwels R, Holgate ST, Shahane A, Zhang J, Reiss TF, Szczeklik A.

Am J Respir Crit Care Med. 2002 Jan 1;165(1):9-14.

PMID:
11779723
17.

Montelukast for persistent asthma.

Szczeklik A, Mastalerz L, Nizankowska E, Sanak M.

Lancet. 2001 Oct 27;358(9291):1456-7. No abstract available.

PMID:
11705519
18.

[Selective cyclooxygenase 2 inhibitors (COX-2)].

Mejza F, Nizankowska E.

Postepy Hig Med Dosw. 2001;55(2):287-302. Review. Polish.

PMID:
11468975
19.

[Goodpasture's syndrome].

Marciniak-Sroka J, Nizankowska E.

Pol Arch Med Wewn. 2000 Dec;104(6):889-95. Review. Polish. No abstract available.

PMID:
11424669
20.

Safety of a specific COX-2 inhibitor in aspirin-induced asthma.

Szczeklik A, Nizankowska E, Bochenek G, Nagraba K, Mejza F, Swierczynska M.

Clin Exp Allergy. 2001 Feb;31(2):219-25.

PMID:
11251623
21.

[Coincidence of 20210A prothrombin variant and factor V Leiden predisposing to venous thromboembolism].

Adamek L, Jankowski M, Sanak M, Krzanowski M, Grzanka P, Nizankowska E, Szczeklik A.

Pol Arch Med Wewn. 1999 Dec;102(6):1095-9. Polish.

PMID:
11072547
22.
23.

Clinical features and diagnosis of aspirin induced asthma.

Szczeklik A, Nizankowska E.

Thorax. 2000 Oct;55 Suppl 2:S42-4. Review. No abstract available.

24.

[Asthma and aspirin intolerance].

Nizankowska E, Szczeklik A.

Rev Mal Respir. 2000 Feb;17(1 Pt 2):255-64. Review. French.

PMID:
10902139
25.

Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma.

Nizankowska E, Bestyńska-Krypel A, Cmiel A, Szczeklik A.

Eur Respir J. 2000 May;15(5):863-9.

26.

[Spiral computed tomography in diagnosis of pulmonary embolism].

Grzanka P, Marcinek P, Czaja P, Adamek L, Olszewski C, Nizankowska E, Szczeklik A.

Pol Arch Med Wewn. 1999 May;101(5):437-44. Review. Polish. No abstract available.

PMID:
10740425
27.

Cytogenetic damage and ras p21 oncoprotein levels from patients with chronic obstructive pulmonary disease (COPD), untreated lung cancer and healthy controls.

Cebulska-Wasilewska A, Wierzewska A, Nizankowska E, Graca B, Hughes JA, Anderson D.

Mutat Res. 1999 Dec 16;431(1):123-31.

PMID:
10656491
28.

Examination of ras oncoproteins in human plasma from healthy controls and workers exposed to petroleum emissions, including benzene-related compounds.

Anderson D, Hughes JA, Brinkworth MH, Cebulska-Wasilewska A, Nizankowska E, Graca B, Veidebaum T, Peltonen K, Sorsa M.

Mutat Res. 1999 Sep 30;445(2):167-73.

PMID:
10575427
29.

Salmeterol prevents aspirin-induced attacks of asthma and interferes with eicosanoid metabolism.

Szczeklik A, Dworski R, Mastalerz L, Prokop A, Sheller JR, Nizankowska E, Cmiel A, Oates JA.

Am J Respir Crit Care Med. 1998 Oct;158(4):1168-72.

PMID:
9769277
30.

Ras p21 protein levels in human plasma from patients with chronic obstructive pulmonary disease (COPD) compared with lung cancer patients and healthy controls.

Anderson D, Hughes JA, Cebulska-Wasilewska A, Nizankowska E, Graca B.

Mutat Res. 1998 Jul 17;403(1-2):229-35.

PMID:
9726023
31.

Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma.

Milewski M, Mastalerz L, Nizankowska E, Szczeklik A.

J Allergy Clin Immunol. 1998 May;101(5):581-6.

PMID:
9600492
32.

Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics.

Dahlén B, Nizankowska E, Szczeklik A, Zetterström O, Bochenek G, Kumlin M, Mastalerz L, Pinis G, Swanson LJ, Boodhoo TI, Wright S, Dubé LM, Dahlén SE.

Am J Respir Crit Care Med. 1998 Apr;157(4 Pt 1):1187-94.

PMID:
9563738
33.

Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma.

Cowburn AS, Sladek K, Soja J, Adamek L, Nizankowska E, Szczeklik A, Lam BK, Penrose JF, Austen FK, Holgate ST, Sampson AP.

J Clin Invest. 1998 Feb 15;101(4):834-46.

34.

Intranasal fluticasone propionate for chronic eosinophilic rhinitis in patients with aspirin-induced asthma.

Mastalerz L, Milewski M, Duplaga M, Nizankowska E, Szczeklik A.

Allergy. 1997 Sep;52(9):895-900.

PMID:
9298173
35.

Aspirin-induced asthma and HLA-DRB1 and HLA-DPB1 genotypes.

Dekker JW, Nizankowska E, Schmitz-Schumann M, Pile K, Bochenek G, Dyczek A, Cookson WO, Szczeklik A.

Clin Exp Allergy. 1997 May;27(5):574-7.

PMID:
9179433
36.

Profound overexpression of leukotriene C4 synthase in bronchial biopsies from aspirin-intolerant asthmatic patients.

Sampson AP, Cowburn AS, Sladek K, Adamek L, Nizankowska E, Szczeklik A, Lam BK, Penrose JF, Austen KF, Holgate ST.

Int Arch Allergy Immunol. 1997 May-Jul;113(1-3):355-7. No abstract available.

PMID:
9130576
37.

Factors affecting various biomarkers in untreated lung cancer patients and healthy donors.

Anderson D, Hughes JA, Nizankowska E, Graca B, Cebulska-Wasilewska A, Wierzewska A, Kasper E.

Environ Mol Mutagen. 1997;30(2):205-16.

PMID:
9329645
38.

Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics.

Szczeklik A, Sladek K, Dworski R, Nizankowska E, Soja J, Sheller J, Oates J.

Am J Respir Crit Care Med. 1996 Dec;154(6 Pt 1):1608-14.

PMID:
8970343
39.

Cytokine production in human and rat macrophages and dicatechol rooperol and esters.

Guzdek A, Nizankowska E, Allison AC, Kruger PB, Koj A.

Biochem Pharmacol. 1996 Oct 11;52(7):991-8.

PMID:
8831717
40.

[Cough as an adverse effect during angiotensin-converting enzyme inhibitor therapy].

Adamek L, Sładek K, Nizankowska E.

Pol Arch Med Wewn. 1996 Mar;95(3):254-60. Review. Polish. No abstract available.

PMID:
8755857
41.

[Genetic aspects of atopic diseases].

Bochenek G, Nizankowska E.

Pol Arch Med Wewn. 1996 Feb;95(2):160-5. Review. Polish. No abstract available.

PMID:
8677212
42.

Protective and bronchodilator effects of prostaglandin E and salbutamol in aspirin-induced asthma.

Szczeklik A, Mastalerz L, Nizankowska E, Cmiel A.

Am J Respir Crit Care Med. 1996 Feb;153(2):567-71.

PMID:
8564099
43.

ras oncoproteins in human plasma from lung cancer patients and healthy controls.

Anderson D, Hughes JA, Cebulska-Wasilewska A, Nizankowska E, Graca B.

Mutat Res. 1996 Jan 17;349(1):121-6.

PMID:
8569784
44.

[Nasal provocation tests].

Mastalerz L, Nizankowska E.

Pneumonol Alergol Pol. 1996;64(3-4):229-34. Review. Polish. No abstract available.

PMID:
8754970
45.

[Diagnosis and treatment of chronic cough].

Pinis G, Adamek L, Nizankowska E.

Pneumonol Alergol Pol. 1996;64(3-4):115-22. Polish. No abstract available.

PMID:
8754954
46.

The atopy trait in hypersensitivity to nonsteroidal anti-inflammatory drugs.

Bochenek G, Nizankowska E, Szczeklik A.

Allergy. 1996 Jan;51(1):16-23.

PMID:
8721523
47.

Autoimmune phenomena in bronchial asthma with special reference to aspirin intolerance.

Szczeklik A, Nizankowska E, Serafin A, Dyczek A, Duplaga M, Musial J.

Am J Respir Crit Care Med. 1995 Dec;152(6 Pt 1):1753-6.

PMID:
8520733
48.

Treatment of steroid-dependent bronchial asthma with cyclosporin.

Nizankowska E, Soja J, Pinis G, Bochenek G, Sładek K, Domagała B, Pajak A, Szczeklik A.

Eur Respir J. 1995 Jul;8(7):1091-9.

49.

Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge.

Sladek K, Dworski R, Soja J, Sheller JR, Nizankowska E, Oates JA, Szczeklik A.

Am J Respir Crit Care Med. 1994 Apr;149(4 Pt 1):940-6.

PMID:
8143059
50.

[Allergy to insulin].

Tokarska L, Dziatkowiak H, Nizankowska E.

Pol Tyg Lek. 1994 Jan 3-17;49(1-3):39-42. Review. Polish.

PMID:
8008675

Supplemental Content

Loading ...
Support Center